American Journal of Gastroenterology最新文献

筛选
英文 中文
Using Transparent Cap of Endoloop in Emergency Hemostasis as a Novel Rapid Clot Removal Procedure for Acute Upper Gastrointestinal Hemorrhage. 在急性上消化道大出血的紧急止血中使用透明内环帽作为一种新型的快速血块清除程序。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-08 DOI: 10.14309/ajg.0000000000003045
Zhenhao Ye, Chaoyuan Huang, Yimin Cheng, Wenjing Xu, Shijuan Luo
{"title":"Using Transparent Cap of Endoloop in Emergency Hemostasis as a Novel Rapid Clot Removal Procedure for Acute Upper Gastrointestinal Hemorrhage.","authors":"Zhenhao Ye, Chaoyuan Huang, Yimin Cheng, Wenjing Xu, Shijuan Luo","doi":"10.14309/ajg.0000000000003045","DOIUrl":"10.14309/ajg.0000000000003045","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Chronic Hepatitis B Identification and Surveillance Program Improves Care in an Integrated Health Plan. 慢性乙型肝炎识别和监控计划改善了综合医疗计划中的护理。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-04 DOI: 10.14309/ajg.0000000000003116
Krisna P Chai, Varun Saxena, Suk Seo, Brandon H Horton, Andrew L Avins, Mai Sedki, Joanna B Ready
{"title":"A Chronic Hepatitis B Identification and Surveillance Program Improves Care in an Integrated Health Plan.","authors":"Krisna P Chai, Varun Saxena, Suk Seo, Brandon H Horton, Andrew L Avins, Mai Sedki, Joanna B Ready","doi":"10.14309/ajg.0000000000003116","DOIUrl":"10.14309/ajg.0000000000003116","url":null,"abstract":"<p><strong>Introduction: </strong>Optimal management of patients with chronic hepatitis B (CHB) requires surveillance for hepatocellular carcinoma (HCC) and identification of antiviral therapy candidates, but few dedicated CHB surveillance models have been described. Kaiser Permanente Northern California developed a systematic CHB surveillance and management program in 2012. We report the results of the program's performance over the initial 8-year period.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of all patients with CHB meeting guideline criteria for HCC surveillance. Eligible patients were invited into the Kaiser Permanente Northern California Liver Care Program (LCP), wherein patients receive reminders to obtain semiannual laboratory and imaging surveillance, which are reviewed by nurse practitioners. Treatment-eligible patients are provided with antiviral medications.</p><p><strong>Results: </strong>Since its inception, 14,630 patients met study criteria, and 9,373 (64.1%) enrolled in the LCP. Adherence to imaging recommendations was higher in the LCP-managed group (41.5% of patients in the LCP received ≥80% of recommended imaging compared with 10.9% among patients not enrolled [risk ratio = 3.8; P < 0.001]). Approximately 63% of treatment-eligible patients in both groups received medication, although full-adherence rates were higher in patients managed in the LCP (72.3% vs 63.4%, respectively, P < 0.001). Among the 197 patients who developed HCC, recommended surveillance imaging was performed more frequently among LCP-managed patients (71.4% vs 53.8%, respectively, P < 0.05) who were also significantly more likely to be diagnosed at Barcelona Clinic Liver Cancer Stage 0/A (95.9% vs 74.6%; P < 0.001).</p><p><strong>Discussion: </strong>In this integrated healthcare system, a systematic program for surveilling and managing patients with CHB seemed beneficial for both process and clinical endpoints.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies. 胆石症与炎症性肠病风险增加有关:三项前瞻性队列研究的结果。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-04 DOI: 10.14309/ajg.0000000000003111
Ningning Mi, Man Yang, Lina Wei, Peng Nie, Shukai Zhan, Long H Nguyen, Fang Gao Smith, Animesh Acharjee, Xudong Liu, Junjie Huang, Bin Xia, Jinqiu Yuan, Wenbo Meng
{"title":"Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies.","authors":"Ningning Mi, Man Yang, Lina Wei, Peng Nie, Shukai Zhan, Long H Nguyen, Fang Gao Smith, Animesh Acharjee, Xudong Liu, Junjie Huang, Bin Xia, Jinqiu Yuan, Wenbo Meng","doi":"10.14309/ajg.0000000000003111","DOIUrl":"10.14309/ajg.0000000000003111","url":null,"abstract":"<p><strong>Introduction: </strong>Gallstone diseases affect intestinal inflammation, bile flow, and gut microbiota, which in turn may increase the risk of inflammatory bowel disease (IBD). However, epidemiological studies exploring the associations between gallstone diseases and subsequent IBD risk have been limited.</p><p><strong>Methods: </strong>This is a combined analysis of 3 prospective cohort studies (Nurses' Health Study, Nurses' Health Study II, and UK Biobank) and replicated in a case-control study (Chinese IBD Etiology Study). We evaluated the hazard ratios (HRs)/odds ratios (ORs) between gallstone diseases with IBD risk by Cox logistic regression or conditional logistic regression, adjusting for demographic characteristics, lifestyles, comorbidities, and medication usage.</p><p><strong>Results: </strong>We identified 3,480 cases of IBD over 2,127,471 person-years of follow-up in the 3 cohort studies. The participants with gallstone disease had a 38% increase in the risk of IBD (HR 1.38, 95% confidence intervals [CI] 1.21-1.59), 68% increase in Crohn's disease (HR 1.68, 95% CI 1.38-2.06), and 24% increase in ulcerative colitis (HR 1.24, 95% CI 1.03-1.49). In Chinese IBD Etiology Study, we found even larger magnitude of effects between gallstone diseases and IBD risk (IBD: OR 3.03, 95% CI 2.32-3.97; Crohn's disease: OR 5.31; 95% CI 3.71-7.60; ulcerative colitis: OR 1.49; 95% CI 1.07-2.06). There were no major differences in the estimated associations between the presence of unremoved gallstones and prior cholecystectomy with IBD risk.</p><p><strong>Discussion: </strong>Gallstone disease was linked to an increased risk of IBD and its subtypes, independent of traditional risk factors. Further research is needed to confirm these associations and clarify the underlying biological mechanisms.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatitis as a Matter of Fat: The Causal Role of High Intrapancreatic Fat Deposition. 胰腺炎与脂肪有关:胰腺内脂肪高度沉积的致病作用。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-04 DOI: 10.14309/ajg.0000000000003065
Maxim S Petrov
{"title":"Pancreatitis as a Matter of Fat: The Causal Role of High Intrapancreatic Fat Deposition.","authors":"Maxim S Petrov","doi":"10.14309/ajg.0000000000003065","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003065","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multicentric Study. 肝功能障碍和全身炎症导致肝硬化急性失代偿期器官衰竭:一项多中心研究
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-04 DOI: 10.14309/ajg.0000000000003115
Nipun Verma, Akash Roy, Arun Valsan, Pratibha Garg, Samonee Ralmilay, Venkitesh Girish, Parminder Kaur, Sahaj Rathi, Arka De, Madhumita Premkumar, Sunil Taneja, Mahesh Kumar Goenka, Ajay Duseja
{"title":"Liver Dysfunction and Systemic Inflammation Drive Organ Failures in Acute Decompensation of Cirrhosis: A Multicentric Study.","authors":"Nipun Verma, Akash Roy, Arun Valsan, Pratibha Garg, Samonee Ralmilay, Venkitesh Girish, Parminder Kaur, Sahaj Rathi, Arka De, Madhumita Premkumar, Sunil Taneja, Mahesh Kumar Goenka, Ajay Duseja","doi":"10.14309/ajg.0000000000003115","DOIUrl":"10.14309/ajg.0000000000003115","url":null,"abstract":"<p><strong>Introduction: </strong>Hospitalized patients with acute decompensation (AD) of cirrhosis are at risk of progressing to acute-on-chronic liver failure (ACLF), significantly increasing their mortality. The aim of this study was to identify key predictors and patient trajectories predisposing to ACLF.</p><p><strong>Methods: </strong>In this multicenter, prospective study spanning 2 years, clinical, biochemical, and 90-day survival data were collected from 625 patients with AD (European Association for the Study of the Liver criteria) across North, South, and East India. We divided the cohort into a Derivation cohort (DC: 318 patients) and a Validation cohort (VC: 307 patients). Predictive models for pre-ACLF were derived, validated, and compared with established scores such as model for end-stage liver disease (MELD) 3.0 and chronic liver failure Consortium acute decompensation.</p><p><strong>Results: </strong>Of 625 patients (mean age 49 years, 83% male, 77.5% with alcohol-related liver disease), 32.2% progressed to ACLF. Patients progressing to ACLF showed significantly higher bilirubin (10.9 vs 8.1 mg/dL), leukocyte counts (9,400 vs 8,000 per mm 3 ), international normalized ratio (1.9 vs 1.8), and MELD 3.0 (28 vs 25) but lower sodium (131 vs 134 mEq/L) and survival (62% vs 86%) compared with those without progression ( P < 0.05) in the DC. Consistent results were noted with alcohol-associated hepatitis, infection and hepatic encephalopathy as additional risk factors in VC. Liver failure at presentation (odds ratio: 2.4 [in DC], 6.9 [in VC]) and the 7-day trajectories of bilirubin, international normalized ratio, and MELD 3.0 significantly predicted ACLF progression ( P < 0.001). A new pre-ACLF model showed superior predictive capability (area under the curve of 0.71 in DC and 0.82 in VC) compared with MELD 3.0 and chronic liver failure Consortium acute decompensation scores ( P < 0.05).</p><p><strong>Discussion: </strong>Approximately one-third of AD patients in this Indian cohort rapidly progressed to ACLF, resulting in high mortality. Early identification of patients at risk can guide targeted interventions to prevent ACLF.</p>","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minding Reflux. 注意反流
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-04 DOI: 10.14309/ajg.0000000000003069
André J P M Smout
{"title":"Minding Reflux.","authors":"André J P M Smout","doi":"10.14309/ajg.0000000000003069","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003069","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease? 更正为:炎症性肠病患者的护理为何如此困难?
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-03 DOI: 10.14309/ajg.0000000000003051
Maria T Abreu, Lawrence R Kosinski
{"title":"Correction to: How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?","authors":"Maria T Abreu, Lawrence R Kosinski","doi":"10.14309/ajg.0000000000003051","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003051","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142363980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons From COBALT: Will the Bell Also Toll for Thee? COBALT 的教训:钟声也会为你敲响吗?
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-02 DOI: 10.14309/ajg.0000000000003061
John Moore Vierling, Paul J Pockros
{"title":"Lessons From COBALT: Will the Bell Also Toll for Thee?","authors":"John Moore Vierling, Paul J Pockros","doi":"10.14309/ajg.0000000000003061","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003061","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142360942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study Design 101: Estimation of Treatment Effects in RCTs Should Be Based on Between-Arm Contrasts, Not Observed Outcome Changes Within Treatment Arms. 研究设计 101:RCT 中治疗效果的估计应基于臂间对比,而非治疗臂内观察到的结果变化。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-02 DOI: 10.14309/ajg.0000000000003034
Darren L Dahly, Tim P Morris
{"title":"Study Design 101: Estimation of Treatment Effects in RCTs Should Be Based on Between-Arm Contrasts, Not Observed Outcome Changes Within Treatment Arms.","authors":"Darren L Dahly, Tim P Morris","doi":"10.14309/ajg.0000000000003034","DOIUrl":"https://doi.org/10.14309/ajg.0000000000003034","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142360943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic Head Cancer Leading to Pancreatic Pseudocyst Resolved by Colonic Fistula Formation. 胰头癌导致的胰腺假性囊肿通过结肠瘘管的形成而缓解。
IF 8 1区 医学
American Journal of Gastroenterology Pub Date : 2024-10-01 Epub Date: 2024-02-19 DOI: 10.14309/ajg.0000000000002724
Hideaki Kazumori, Tomoya Hasegawa
{"title":"Pancreatic Head Cancer Leading to Pancreatic Pseudocyst Resolved by Colonic Fistula Formation.","authors":"Hideaki Kazumori, Tomoya Hasegawa","doi":"10.14309/ajg.0000000000002724","DOIUrl":"10.14309/ajg.0000000000002724","url":null,"abstract":"","PeriodicalId":7608,"journal":{"name":"American Journal of Gastroenterology","volume":" ","pages":"1965"},"PeriodicalIF":8.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139899198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信